Sooryanarayana Varambally, Ph.D., MBA
Sooryanarayana Varambally, Ph.D., MBA
Professor, Department of Pathology, UAB, University of Alabama at Birmingham
Verified email at - Homepage
Cited by
Cited by
UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses
DS Chandrashekar, B Bashel, SAH Balasubramanya, CJ Creighton, ...
Neoplasia 19 (8), 649-658, 2017
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ...
science 310 (5748), 644-648, 2005
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ...
Nature 419 (6907), 624-629, 2002
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
A Sreekumar, LM Poisson, TM Rajendiran, AP Khan, Q Cao, J Yu, ...
Nature 457 (7231), 910-914, 2009
Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
DR Rhodes, S Kalyana-Sundaram, V Mahavisno, R Varambally, J Yu, ...
Neoplasia 9 (2), 166-180, 2007
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ...
Nature 412 (6849), 822-826, 2001
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer, Q Cao, S Varambally, R Shen, I Ota, SA Tomlins, D Ghosh, ...
Proceedings of the national academy of sciences 100 (20), 11606-11611, 2003
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ...
Nature medicine 22 (3), 298-305, 2016
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer
S Varambally, Q Cao, RS Mani, S Shankar, X Wang, B Ateeq, B Laxman, ...
science 322 (5908), 1695-1699, 2008
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression
J Yu, J Yu, RS Mani, Q Cao, CJ Brenner, X Cao, X Wang, L Wu, J Li, M Hu, ...
Cancer cell 17 (5), 443-454, 2010
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ...
Nature 448 (7153), 595-599, 2007
UALCAN: An update to the integrated cancer data analysis platform
DS Chandrashekar, SK Karthikeyan, PK Korla, H Patel, AR Shovon, ...
Neoplasia 25, 18-27, 2022
α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer
MA Rubin, M Zhou, SM Dhanasekaran, S Varambally, TR Barrette, ...
Jama 287 (13), 1662-1670, 2002
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ...
Cancer cell 8 (5), 393-406, 2005
Role of the TMPRSS2-ERG gene fusion in prostate cancer
SA Tomlins, B Laxman, S Varambally, X Cao, J Yu, BE Helgeson, Q Cao, ...
Neoplasia 10 (2), 177-IN9, 2008
Autoantibody signatures in prostate cancer
X Wang, J Yu, A Sreekumar, S Varambally, R Shen, D Giacherio, R Mehra, ...
New England Journal of Medicine 353 (12), 1224-1235, 2005
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program
RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ...
Cancer research 64 (24), 9209-9216, 2004
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Q Cao, J Yu, SM Dhanasekaran, JH Kim, RS Mani, SA Tomlins, R Mehra, ...
Oncogene 27 (58), 7274-7284, 2008
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
N Palanisamy, B Ateeq, S Kalyana-Sundaram, D Pflueger, ...
Nature medicine 16 (7), 793-798, 2010
Probabilistic model of the human protein-protein interaction network
DR Rhodes, SA Tomlins, S Varambally, V Mahavisno, T Barrette, ...
Nature biotechnology 23 (8), 951-959, 2005
The system can't perform the operation now. Try again later.
Articles 1–20